Genmab AS (GMAB) — Cash Flow-to-Debt Ratio
Genmab AS (GMAB) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of $300.34 Million could theoretically repay 0% of its total liabilities ($7.01 Billion) in one year. See Genmab AS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genmab AS Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Genmab AS across 24 annual periods. For the full cash flow conversion analysis, see how efficiently does Genmab AS generate cash.
Annual Cash Flow-to-Debt Ratio for Genmab AS (2002–2025)
Year-by-year debt coverage analysis for Genmab AS. Check Genmab AS cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | $1.19 Billion | $7.01 Billion | ▼ -80.1% |
| 2024 | 0.85x | $7.77 Billion | $9.11 Billion | ▼ -57.5% |
| 2023 | 2.01x | $7.38 Billion | $3.68 Billion | ▲ +45.5% |
| 2022 | 1.38x | $3.91 Billion | $2.84 Billion | ▲ +50.5% |
| 2021 | 0.92x | $2.23 Billion | $2.43 Billion | ▼ -71.2% |
| 2020 | 3.18x | $6.43 Billion | $2.02 Billion | ▲ +163.0% |
| 2019 | 1.21x | $1.33 Billion | $1.10 Billion | ▼ -46.8% |
| 2018 | 2.27x | $1.01 Billion | $446.64 Million | ▼ -52.7% |
| 2017 | 4.80x | $1.59 Billion | $330.75 Million | ▲ +503.3% |
| 2016 | 0.80x | $327.72 Million | $411.54 Million | ▲ +6.3% |
| 2015 | 0.75x | $311.45 Million | $415.83 Million | ▲ +370.7% |
| 2014 | 0.16x | $132.67 Million | $833.74 Million | ▲ +233.3% |
| 2013 | -0.12x | $-128.00 Million | $1.07 Billion | ▼ -320.5% |
| 2012 | 0.05x | $70.92 Million | $1.31 Billion | ▲ +113.4% |
| 2011 | -0.41x | $-437.23 Million | $1.08 Billion | ▼ -312.0% |
| 2010 | 0.19x | $268.17 Million | $1.40 Billion | ▲ +131.0% |
| 2009 | -0.62x | $-570.06 Million | $924.34 Million | ▼ -28.6% |
| 2008 | -0.48x | $-513.33 Million | $1.07 Billion | ▼ -202.0% |
| 2007 | 0.47x | $505.90 Million | $1.08 Billion | ▲ +124.4% |
| 2006 | -1.93x | $-379.62 Million | $197.05 Million | ▼ -132.4% |
| 2005 | -0.83x | $-208.64 Million | $251.66 Million | ▲ +79.5% |
| 2004 | -4.04x | $-367.70 Million | $90.92 Million | ▼ -25.3% |
| 2003 | -3.23x | $-302.36 Million | $93.67 Million | ▼ -92.6% |
| 2002 | -1.68x | $-308.32 Million | $183.97 Million | — |